Company intelligence / Profile preview

Beli

United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Beli sells clinically designed, science-backed fertility and prenatal supplements for women and men, with consumer testimonials reporting improved conception outcomes, cycle regulation, and sperm quality. Products are manufactured in FDA-registered, GMP-certified U.S. facilities, with no known clinical trial results.

Therapeutic areas: Women's HealthOtherMetabolic Disorders
Modalities: NutraceuticalSmall molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on Beli.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beli.

Explore the full profile